BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8591725)

  • 1. Metabolism and pharmacokinetics of a double prodrug of ganciclovir in the rat and monkey.
    Krasny HC; Beauchamp L; Krenitsky TA; de Miranda P
    Drug Metab Dispos; 1995 Nov; 23(11):1242-7. PubMed ID: 8591725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular disposition of novel lipophilic diester prodrugs of ganciclovir following intravitreal administration using microdialysis.
    Macha S; Duvvuri S; Mitra AK
    Curr Eye Res; 2004 Feb; 28(2):77-84. PubMed ID: 14972713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, physicochemical properties and antiviral activities of ester prodrugs of ganciclovir.
    Patel K; Trivedi S; Luo S; Zhu X; Pal D; Kern ER; Mitra AK
    Int J Pharm; 2005 Nov; 305(1-2):75-89. PubMed ID: 16242278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravitreal toxicology and duration of efficacy of a novel antiviral lipid prodrug of ganciclovir in liposome formulation.
    Cheng L; Hostetler KY; Chaidhawangul S; Gardner MF; Beadle JR; Keefe KS; Bergeron-Lynn G; Severson GM; Soules KA; Mueller AJ; Freeman WR
    Invest Ophthalmol Vis Sci; 2000 May; 41(6):1523-32. PubMed ID: 10798672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corneal permeation of ganciclovir: mechanism of ganciclovir permeation enhancement by acyl ester prodrug design.
    Tirucherai GS; Dias C; Mitra AK
    J Ocul Pharmacol Ther; 2002 Dec; 18(6):535-48. PubMed ID: 12537680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Superior cytostatic activity of the ganciclovir elaidic acid ester due to the prolonged intracellular retention of ganciclovir anabolites in herpes simplex virus type 1 thymidine kinase gene-transfected tumor cells.
    Balzarini J; Degrève B; Andrei G; Neyts J; Sandvold M; Myhren F; de Clercq E
    Gene Ther; 1998 Mar; 5(3):419-26. PubMed ID: 9614564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and metabolism of the prodrug DB289 (2,5-bis[4-(N-methoxyamidino)phenyl]furan monomaleate) in rat and monkey and its conversion to the antiprotozoal/antifungal drug DB75 (2,5-bis(4-guanylphenyl)furan dihydrochloride).
    Midgley I; Fitzpatrick K; Taylor LM; Houchen TL; Henderson SJ; Wright SJ; Cybulski ZR; John BA; McBurney A; Boykin DW; Trendler KL
    Drug Metab Dispos; 2007 Jun; 35(6):955-67. PubMed ID: 17360833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of latanoprost in the cynomolgus monkey. 1st communication: single intravenous, oral or topical administration on the eye.
    Sjöquist B; Tajallaei S; Stjernschantz J
    Arzneimittelforschung; 1999 Mar; 49(3):225-33. PubMed ID: 10219466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic fate and pharmacokinetics of the acyclovir prodrug valaciclovir in cynomolgus monkeys.
    de Miranda P; Burnette TC
    Drug Metab Dispos; 1994; 22(1):55-9. PubMed ID: 8149890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitreal pharmacokinetics of dipeptide monoester prodrugs of ganciclovir.
    Majumdar S; Kansara V; Mitra AK
    J Ocul Pharmacol Ther; 2006 Aug; 22(4):231-41. PubMed ID: 16910863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a novel intraocular drug-delivery system using crystalline lipid antiviral prodrugs of ganciclovir and cyclic cidofovir.
    Cheng L; Hostetler KY; Lee J; Koh HJ; Beadle JR; Bessho K; Toyoguchi M; Aldern K; Bovet JM; Freeman WR
    Invest Ophthalmol Vis Sci; 2004 Nov; 45(11):4138-44. PubMed ID: 15505067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular disposition of ganciclovir and its monoester prodrugs following intravitreal administration using microdialysis.
    Macha S; Mitra AK
    Drug Metab Dispos; 2002 Jun; 30(6):670-5. PubMed ID: 12019194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Species and organ differences in first-pass metabolism of the ester prodrug L-751,164 in dogs and monkeys. In vivo and in vitro studies.
    Prueksaritanont T; Gorham LM; Ellis JD; Fernandez-Metzler C; Deluna P; Gehret JR; Strong KL; Hochman JH; Askew BC; Duggan ME; Gilbert JD; Lin JH; Vyas KP
    Drug Metab Dispos; 1996 Nov; 24(11):1263-71. PubMed ID: 8937862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and safety of viramidine, a prodrug of ribavirin, in healthy volunteers.
    Lin CC; Philips L; Xu C; Yeh LT
    J Clin Pharmacol; 2004 Mar; 44(3):265-75. PubMed ID: 14973309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corneal absorption and anterior chamber pharmacokinetics of dipeptide monoester prodrugs of ganciclovir (GCV): in vivo comparative evaluation of these prodrugs with Val-GCV and GCV in rabbits.
    Gunda S; Hariharan S; Mitra AK
    J Ocul Pharmacol Ther; 2006 Dec; 22(6):465-76. PubMed ID: 17238815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo evaluations of the metabolism, pharmacokinetics, and bioavailability of ester prodrugs of L-767,679, a potent fibrinogen receptor antagonist: an approach for the selection of a prodrug candidate.
    Prueksaritanont T; Gorham LM; Breslin MJ; Hutchinson JH; Hartman GD; Vyas KP; Baillie TA
    Drug Metab Dispos; 1997 Aug; 25(8):978-84. PubMed ID: 9280406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of latanoprost in the cynomolgus monkey. 2nd communication: repeated topical administration on the eye.
    Sjöquist B; Uhlin A; Byding P; Stjernschantz J
    Arzneimittelforschung; 1999 Mar; 49(3):234-9. PubMed ID: 10219467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ocular pharmacokinetics and bioavailability of 0.2% ganciclovir in-situ gelling eye drops].
    Zhang JJ; Gao CF; Wang LY
    Zhonghua Yan Ke Za Zhi; 2006 Jul; 42(7):637-41. PubMed ID: 17081425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular imaging with 123I-FIAU, 18F-FUdR, 18F-FET, and 18F-FDG for monitoring herpes simplex virus type 1 thymidine kinase and ganciclovir prodrug activation gene therapy of cancer.
    Wang HE; Yu HM; Liu RS; Lin M; Gelovani JG; Hwang JJ; Wei HJ; Deng WP
    J Nucl Med; 2006 Jul; 47(7):1161-71. PubMed ID: 16818951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of a HSV thymidine kinase stimulating substance, scopadulciol, in improving the efficacy of cancer gene therapy.
    Hayashi K; Lee JB; Maitani Y; Toyooka N; Nemoto H; Hayashi T
    J Gene Med; 2006 Aug; 8(8):1056-67. PubMed ID: 16779868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.